An alternative POLDIP3 transcript promotes hepatocellular carcinoma progression.
暂无分享,去创建一个
[1] R. Sivaperumal,et al. Protective effects of dieckol on N-nitrosodiethylamine induced hepatocarcinogenesis in rats. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[2] P. Maturu,et al. Modulatory role of Pterocarpus santalinus against alcohol-induced liver oxidative/nitrosative damage in rats. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[3] Tengteng Zhu,et al. Long noncoding RNA glypican 3 (GPC3) antisense transcript 1 promotes hepatocellular carcinoma progression via epigenetically activating GPC3 , 2016, The FEBS journal.
[4] Jung-Hwan Yoon,et al. Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[5] T. Tilli,et al. Osteopontin splice variants expression is involved on docetaxel resistance in PC3 prostate cancer cells , 2016, Tumor Biology.
[6] Marietta Y. W. T. Lee,et al. PDIP46 (DNA polymerase δ interacting protein 46) is an activating factor for human DNA polymerase δ , 2016, Oncotarget.
[7] K. Hashem,et al. Cerium oxide nanoparticles alleviate oxidative stress and decreases Nrf-2/HO-1 in D-GALN/LPS induced hepatotoxicity. , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[8] D. Rio,et al. Mechanisms and Regulation of Alternative Pre-mRNA Splicing. , 2015, Annual review of biochemistry.
[9] K. Palm,et al. Diagnostic significance of alternative splice variants of REST and DOPEY1 in the peripheral blood of patients with breast cancer , 2015, Tumor Biology.
[10] Jessica Zucman-Rossi,et al. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets , 2015, Nature Genetics.
[11] A. Jemal,et al. Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.
[12] E. Borazan,et al. Differential expression of the UGT1A family of genes in stomach cancer tissues , 2015, Tumor Biology.
[13] D. Bates,et al. Hallmarks of alternative splicing in cancer , 2014, Oncogene.
[14] Dan Chen,et al. The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression. , 2014, Cancer cell.
[15] Dino Amadori,et al. ΔNp63 promotes stem cell activity in mammary gland development and basal-like breast cancer by enhancing Fzd7 expression and Wnt signaling , 2014, Nature Cell Biology.
[16] Jing Fang,et al. BCLAF1 and its splicing regulator SRSF10 regulate the tumorigenic potential of colon cancer cells , 2014, Nature Communications.
[17] Jignesh R. Parikh,et al. Alternative splicing of MBD2 supports self-renewal in human pluripotent stem cells. , 2014, Cell stem cell.
[18] Shuhan Sun,et al. A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. , 2014, Cancer cell.
[19] Jian Zhang,et al. Misregulation of pre-mRNA alternative splicing in cancer. , 2013, Cancer discovery.
[20] M. Alló,et al. Alternative splicing: a pivotal step between eukaryotic transcription and translation , 2013, Nature Reviews Molecular Cell Biology.
[21] C. Chenu,et al. Mammalian Sulf1 RNA alternative splicing and its significance to tumour growth regulation , 2012, Tumor Biology.
[22] Fang Wang,et al. The histone deacetylase 4/SP1/microrna‐200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma , 2011, Hepatology.
[23] A. Zell,et al. TDP-43 regulates global translational yield by splicing of exon junction complex component SKAR , 2011, Nucleic acids research.
[24] D. Sahani,et al. HCC and angiogenesis: possible targets and future directions , 2011, Nature Reviews Clinical Oncology.
[25] Lewis R. Roberts,et al. Hepatocellular carcinoma: a global view , 2010, Nature Reviews Gastroenterology &Hepatology.
[26] Shuhan Sun,et al. miR‐17‐5p Promotes migration of human hepatocellular carcinoma cells through the p38 mitogen‐activated protein kinase‐heat shock protein 27 pathway , 2010, Hepatology.
[27] J. Blenis,et al. SKAR Links Pre-mRNA Splicing to mTOR/S6K1-Mediated Enhanced Translation Efficiency of Spliced mRNAs , 2008, Cell.
[28] S. Cory,et al. The Bcl-2 apoptotic switch in cancer development and therapy , 2007, Oncogene.
[29] S. Thorgeirsson,et al. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells , 2006, Nature Medicine.
[30] S. Gygi,et al. SKAR Is a Specific Target of S6 Kinase 1 in Cell Growth Control , 2004, Current Biology.
[31] G. Bonser,et al. Preventable Cancer , 1912, The Indian Medical Gazette.
[32] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.